Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novavax Inc
(NQ:
NVAX
)
16.44
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novavax Inc
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
54
55
Next >
52 Biggest Movers From Friday
January 31, 2022
Gainers Knightscope, Inc. (NASDAQ: KSCP) surged 175.6% to close at $3.40 on Friday. The company, on Thursday, priced its IPO at $10 per share. Imperial Petroleum Inc. (NASDAQ:...
Via
Benzinga
Novavax Could Be the Biggest Bargain in the Market Right Now
January 28, 2022
NVAX stock would benefit if it the company finally wins approval from the FDA
Via
InvestorPlace
Israel Inks COVID-19 Vaccine Deal With Novavax
January 28, 2022
Israel's Ministry of Health has agreed to purchase Novavax Inc's (NASDAQ: NVAX) protein-based COVID-19 vaccine candidate, NVX-CoV2373.
Via
Benzinga
Could Novavax Stock Be Due For A Reversal Soon?
January 24, 2022
Novavax Inc. (NASDAQ:NVAX) shares lost ground Monday fell ...
Via
Benzinga
Novavax Stock May Not Be This Cheap For Long
January 20, 2022
Novavax is expecting approvals from several countries in the coming months and this will take the revenue higher. Buy NVAX stock in the dip.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Uncertain Market Conditions And Good News Make Novavax A Cautious Buy
January 25, 2022
An emergency use authorization in Australia is the latest example of the “yeah but” narrative that has plagued NVAX stock for the past year.
Via
InvestorPlace
Novavax Continues to Require Patience, But It Should Pay Off
January 25, 2022
NVAX stock dropped precipitously of late, but investors with patience and a long view won't lose that patience as revenues start to roll in.
Via
InvestorPlace
Novavax Appears to be Running Out of Options
January 25, 2022
With time appearing to run out and fewer people willing to get vaccinated, NVAX stock seems to be an abandon-ship investment at this point.
Via
InvestorPlace
Looking At Novavax's Recent Whale Trades
January 24, 2022
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on...
Via
Benzinga
Novavax Is Fighting a Losing Battle on Two Fronts
January 24, 2022
Novavax could be losing ground in the vaccine war because it’s fighting a battle on two fronts. This isn’t helping NVAX stock move higher.
Via
InvestorPlace
Worldwide Adoption of Novavax Vaccines Makes It a Winner
January 21, 2022
Novavax can still generate billions of dollars of revenue per year from its shot, making NVAX stock quite attractive at its current levels.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022
January 21, 2022
Upgrades According to Seaport Global, the prior rating for KB Home (NYSE:
Via
Benzinga
Novavax Stock is in a Tough Spot, but its Fortunes Could Improve
January 20, 2022
Once the vaccine maker starts booking big sales internationally, NVAX stock could make a trip back to much higher prices.
Via
InvestorPlace
Novavax Is Oversold, Time To Buy for Future Growth
January 20, 2022
NVAX stock seems oversold. Focus on low-income countries is likely to deliver revenue and cash flows from Covid-19 vaccine sales in 2022.
Via
InvestorPlace
What The Future Might Hold For Novavax Stock
January 20, 2022
The stock trades below both the 50-day moving average and the 200-day moving average which indicates the sentiment is bearish.
Via
Talk Markets
What The Future Might Hold For Novavax Stock
January 20, 2022
Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Thur...
Via
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In...
Via
Benzinga
Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine
January 20, 2022
Novavax Inc (NASDAQ: NVAX) said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine. What Happened: The Maryland-based...
Via
Benzinga
This Is What Whales Are Betting On Novavax
January 19, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 34 strange trades. If we...
Via
Benzinga
Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today
January 18, 2022
Shares of vaccine makers, including Moderna Inc (NASDAQ:M...
Via
Benzinga
Novavax Still Has Not Received an FDA EUA as the Market Waits
January 14, 2022
NVAX stock looks like a good buy here, especially if analysts' revenue forecasts for 2022 come to pass as forecast and NVAX bounces back.
Via
InvestorPlace
12 Things for SQ Stock Investors to Know About Block’s Bitcoin Mining Plans
January 14, 2022
Block (SQ) stock is in the news Friday following news that the payment services company plans to get into Bitcoin (BTC) mining.
Via
InvestorPlace
NVAX Stock Alert: Why Is Novavax Plunging Today?
January 14, 2022
With the vaccine mandate failing to pass, companies like Novavax face an uncertain future. Here's why bears are circling NVAX stock.
Via
InvestorPlace
Why Moderna, Novavax And Other Vaccine Stocks Are Extending Losses Today
January 14, 2022
COVID-19 vaccine stocks are all retreating sharply for a second day running on Friday. The U.S. Supreme Court on Thursday ruled against President Joe Biden's quest to...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 14, 2022
Gainers Molecular Partners (NASDAQ:MOLN) shares moved upwards by 11.9% to $31.66 during Friday's pre-market session. The market value of their outstanding shares is at...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 14, 2022
Happy Friday, trader! We're starting off the day right with an overview of the biggest pre-market stock movers for today!
Via
InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
January 14, 2022
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday. NextPlay Technologies, Inc...
Via
Benzinga
Here Are a Couple Billion Reasons to Hold Novavax Stock
January 14, 2022
NVAX stock just came down to an attractive price, and the future looks bright as Novavax continues its expansion into international markets.
Via
InvestorPlace
48 Biggest Movers From Yesterday
January 14, 2022
Gainers Singularity Future Technology Ltd. (NASDAQ: SGLY) shares rose 25.9% to settle at $5.01 on Thursday. MedAvail Holdings, Inc (NASDAQ: MDVL) gained 24.4% to settle at $1.58...
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.